 |
 |
o
|
||||||||
|
|
|
|
|
|
|
||
|
|
|
||||||
|
|
| Home |
Volume 7: No. 3, May 2010
| ATP III Risk Group | % of NYC Adults |
|---|---|
| Low | |
| Normal LDL cholesterol | 59.5 |
| High LDL cholesterol/aware | 4.3 |
| High LDL cholesterol/unaware | 1.0 |
| Moderate | |
| Normal LDL cholesterol | 7.2 |
| High LDL cholesterol/aware | 2.8 |
| High LDL cholesterol/unaware | 0.5 |
| Moderately high | |
| Normal LDL cholesterol | 2.6 |
| High LDL cholesterol/aware | 2.5 |
| High LDL cholesterol/unaware | 1.5 |
| High | |
| Normal LDL cholesterol | 2.8 |
| High LDL cholesterol/aware | 10.1 |
| High LDL cholesterol/unaware | 5.0 |
Figure. Age-standardized prevalence of high LDL cholesterol among NYC adults by ATP-III risk category (5,14), New York City Health and Nutrition Examination Survey, 2004. High LDL cholesterol defined as currently taking cholesterol-lowering medications or having LDL cholesterol levels at or greater than the ATP-III risk-specific thresholds recommended for initiation of drug therapy: ≥100 mg/dL for the high-risk group, ≥130 mg/dL for the moderately high-risk group, ≥160 mg/dL for the moderate-risk group, and ≥190 mg/dL for the low-risk group.
|
|
|
|
|
|
|
|
The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.
Privacy Policy | Accessibility This page last reviewed October 25, 2011
|
|
